Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Retatrutide does not yet have dedicated cardiovascular or renal outcome trials, though Phase 3 studies evaluating these endpoints are currently enrolling participants with expected completion in 2026
BPC-157 is a synthetic pentadecapeptide derived from human gastric juice with an extensive preclinical tissue repair and neuroprotection research database
J Biol Chem (2002) 277:4073541
US$ 21.23
US$ 27.32
US$ 20.02
US$ 25.42
US$ 29.60
US$ 26.28
US$ 24.04
